Chinyang Chemical

At a glance

Chinyang Chemical filed 32 disclosures in the last 12 months, including 7 insider, 1 5% holder and 1 buyback. The most recent key filing was on Sep 4: A major holder's stake rose from 68.20% to 70.08% (open-market buy).

Revenue for 2025 was ₩18.6B, down 24.3% on 2024. It made an operating loss of ₩743.3M. Debt was 107% of equity at year end. The latest interim report (2026 H1) shows revenue of ₩10.9B and operating loss of ₩72.8M.

The 2025 annual report lists 37 employees with an average tenure of 8.8 years and average pay of ₩51M. Its 4 directors and auditors were paid ₩70M each on average. It paid no cash dividend for 2025. ㈜진양홀딩스 and related parties held 68.20% at year end.

Of 1 recent 5%+ holder report, 1 raised and 0 cut a stake; the largest stake reported was 70.08% on Sep 4.

From the 2025 annual report

Staff: 37 (36 men, 1 women), of whom 0 on fixed-term contracts. Total pay for the year: ₩1.9B. Directors and auditors: 4, paid ₩278M in total.

No cash dividend was paid for 2025.

Largest shareholder

㈜진양홀딩스 holds 68.20%; with 0 related parties the group holds 68.20% of common shares at year end.

Auditor: 삼화회계법인 · opinion: Unqualified.

Source: 2025 annual business report (DART). How figures are combined

Financial summary

5%+ holder reports